Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Nephrology / Hypertension Recent Publications
Shubhada N. Ahya, MD
Early onset of tenofovir-induced renal failure: case report and review of the literature.
Patel SM, Zembower TR, Palella F, Kanwar YS, Ahya SN
TheScientificWorldJournal. 2007;7:1140-8.
PMID: 17660885

Stabilization of Glomerular Filtration Rate in Advanced Chronic Kidney Disease: A Two-Year Follow-up of a Cohort of Chronic Kidney Disease Patients Stages 4 and 5.
Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D
Advances in chronic kidney disease. 2007;14(1):105-12.
PMID: 17200050

Acid-base and potassium disorders in liver disease.
Ahya SN, Jose Soler M, Levitsky J, Batlle D
Seminars in nephrology. 2006 Nov;26(6):466-70.
PMID: 17275584

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Joist HE, Ahya SN, Giles K, Norwood K, Slatopolsky E, Coyne DW
Clinical nephrology. 2006;65(5):335-41.
PMID: 16724654

Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Singri N, Johnstone D, Paparello J, Khosla N, Ahya SN, Ghossein C, Schlueter W, Rosa R, Batlle D, Levin ML
Advances in chronic kidney disease. 2004 Oct;11(4):398-403.
PMID: 15492978

Acute renal failure.
Singri N, Ahya SN, Levin ML
JAMA : the journal of the American Medical Association. 2003;289(6):747-51.
PMID: 12585954

Daniel C. Batlle, MD
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
Batlle D, Soler MJ, Wysocki J
Current opinion in nephrology and hypertension. 2008;17(3):250-7.
PMID: 18408475

Angiotensin-converting Enzyme 2: Possible Role in Hypertension and Kidney Disease.
Wysocki J, González-Pacheco FR, Batlle D
Current hypertension reports. 2008;10(1):70-7.
PMID: 18367030

ACE2 and the Kidney.
Soler MJ, Wysocki J, Batlle D
Experimental physiology. 2008.
PMID: 18223023

High CO(2) Levels Impair Alveolar Epithelial Function Independently of pH.
Briva A, Vadász I, Lecuona E, Welch LC, Chen J, Dada LA, Trejo HE, Dumasius V, Azzam ZS, Myrianthefs PM, Batlle D, Gruenbaum Y, Sznajder JI
PLoS ONE. 2007 Nov;2(11):e1238.
PMID: 18043745

ACE2 inhibition worsens glomerular injury associated with increased ACE expression in streptozotocin-induced diabetic mice.
Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D
Kidney international. 2007.
PMID: 17579661

Ca2+ /H+ exchange via the plasma membrane Ca2+ ATPase in skeletal muscle.
Desantiago JJ, Batlle DD, Khilnani MM, Dedhia SS, Kulczyk JJ, Duque RR, Ruiz JJ, Pena-Rasgado CC, Rasgado-Flores H
Frontiers in bioscience : a journal and virtual library. 2007;10:4641-4660.
PMID: 17485401

Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Chen S, Jalandhara N, Batlle D
Nature clinical practice. Nephrology. 2007;3(4):233.
PMID: 17389893

Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Chen S, Jalandhara N, Batlle D
Nature clinical practice. Nephrology. 2007;3(2):82-95.
PMID: 17251996

Stabilization of Glomerular Filtration Rate in Advanced Chronic Kidney Disease: A Two-Year Follow-up of a Cohort of Chronic Kidney Disease Patients Stages 4 and 5.
Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D
Advances in chronic kidney disease. 2007;14(1):105-12.
PMID: 17200050

Intestinal ileus as a possible cause of hypobicarbonatemia.
Serrano A, Chilakapati RK, Ghanayem AJ, Yuan Y, Alberts J, Stephen C, Rombola G, Batlle D
TheScientificWorldJournal. 2007;7:75-9.
PMID: 17334600

Progress in retarding the progression of advanced chronic kidney disease: Grounds for optimism.
Batlle D, Ramadugu P, Soler MJ
Kidney international. Supplement. 2006 Dec(104):S40-4.
PMID: 17109001

Acid-base and potassium disorders: clinical aspects.
Batlle D
Seminars in nephrology. 2006 Nov;26(6):403.
PMID: 17275577

Acid-base and potassium disorders in liver disease.
Ahya SN, Jose Soler M, Levitsky J, Batlle D
Seminars in nephrology. 2006 Nov;26(6):466-70.
PMID: 17275584

Distal renal tubular acidosis and the potassium enigma.
Batlle D, Moorthi KM, Schlueter W, Kurtzman N
Seminars in nephrology. 2006 Nov;26(6):471-8.
PMID: 17275585

ACE and ACE2 activity in diabetic mice.
Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D
Diabetes. 2006;55(7):2132-9.
PMID: 16804085

Carlos Margarit in memoriam, 1950-2005.
Batlle D
TheScientificWorldJournal. 2006;6:318-52.
PMID: 16547585

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B, Williams L, Andress DL, Sprague SM
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006;47(2):263-76.
PMID: 16431255

A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Abboud H, Coyne D, Smolenski O, Anger M, Lunde N, Qiu P, Hippensteel R, Pradhan RS, Palaparthy RV, Kavanaugh A, Melnick JZ, Williams LA, Batlle D
American journal of nephrology. 2006;26(1):105-14.
PMID: 16543714

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D
Journal of the American Society of Nephrology : JASN. 2006;17(11):3067-75.
PMID: 17021266

Acid-base regulation: basic mechanisms.
Batlle D
Seminars in nephrology. 2006;26(5):333.
PMID: 17071326

Kidney vacuolar H+ -ATPase: physiology and regulation.
Valles P, Lapointe MS, Wysocki J, Batlle D
Seminars in nephrology. 2006;26(5):361-74.
PMID: 17071330

Antiproteinuric effect of oral paricalcitol in chronic kidney disease.
Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D
Kidney international. 2005 Dec;68(6):2823-8.
PMID: 16316359

Angiotensin II and renal tubular ion transport.
Valles P, Wysocki J, Batlle D
TheScientificWorldJournal. 2005;5:680-90.
PMID: 16142301

Angiotensin II increases H+-ATPase B1 subunit expression in medullary collecting ducts.
Valles P, Wysocki J, Salabat MR, Cokic I, Ye M, LaPointe MS, Batlle D
Hypertension. 2005;45(4):818-23.
PMID: 15699454

Guest editorial: diabetic kidney disease.
Batlle D, McGill J, Williams M
Advances in chronic kidney disease. 2005;12(2):126-7.
PMID: 15822048

Predicting the development of diabetic nephropathy and its progression.
William J, Hogan D, Batlle D
Advances in chronic kidney disease. 2005;12(2):202-11.
PMID: 15822056

Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease?
Moorthi KM, Hogan D, Lurbe E, Redon J, Batlle D
Current hypertension reports. 2004 Oct;6(5):393-9.
PMID: 15341693

Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Singri N, Johnstone D, Paparello J, Khosla N, Ahya SN, Ghossein C, Schlueter W, Rosa R, Batlle D, Levin ML
Advances in chronic kidney disease. 2004 Oct;11(4):398-403.
PMID: 15492978

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?
Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D
Hypertension. 2004;43(5):1120-5.
PMID: 15078862

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG
The American journal of medicine. 2003;115(4):291-7.
PMID: 12967694

The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells.
Lecuona E, Ridge K, Pesce L, Batlle D, Sznajder JI
Molecular biology of the cell. 2003;14(9):3888-97.
PMID: 12972572

Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathy.
Zeng L, Kanwar YS, Amro N, Phillips C, Molitch M, Batlle D, Danesh FR
Kidney international. 2003;63(6):2094-102.
PMID: 12753296

Clinical and cellular markers of diabetic nephropathy.
Batlle D
Kidney international. 2003;63(6):2319-30.
PMID: 12753325

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D
Kidney international. 2003;63(4):1483-90.
PMID: 12631365

Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Coyne DW, Adkinson NF, Nissenson AR, Fishbane S, Agarwal R, Eschbach JW, Michael B, Folkert V, Batlle D, Trout JR, Dahl N, Myirski P, Strobos J, Warnock DG, Ferlecit Investigators
Kidney international. 2003;63(1):217-24.
PMID: 12472786

Sheldon Chen, MD
Diabetic nephropathy: mechanisms of renal disease progression.
Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR
Experimental biology and medicine (Maywood, N.J.). 2008;233(1):4-11.
PMID: 18156300

Interference with TGF-{beta} signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S
American journal of physiology. Renal physiology. 2007.
PMID: 17804483

Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Chen S, Jalandhara N, Batlle D
Nature clinical practice. Nephrology. 2007;3(4):233.
PMID: 17389893

Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Chen S, Jalandhara N, Batlle D
Nature clinical practice. Nephrology. 2007;3(2):82-95.
PMID: 17251996

HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
Xu H, Zeng L, Peng H, Chen S, Jones J, Chew TL, Sadeghi MM, Kanwar YS, Danesh FR
American journal of physiology. Renal physiology. 2006 Nov;291(5):F995-1004.
PMID: 16774905

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S
Journal of the American Society of Nephrology : JASN. 2006 Nov;17(11):3093-104.
PMID: 16988063

ACE and ACE2 activity in diabetic mice.
Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D
Diabetes. 2006;55(7):2132-9.
PMID: 16804085

Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.
Cohen MP, Ziyadeh FN, Chen S
The Journal of laboratory and clinical medicine. 2006;147(5):211-9.
PMID: 16697768

Inhibiting Albumin Glycation Attenuates Dysregulation of VEGFR-1 and Collagen IV Subchain Production and the Development of Renal Insufficiency.
Cohen M, Lautenslager GT, Hud E, Shea E, Chen S, Wang A, Shearman CW
American journal of physiology. Renal physiology. 2006.
PMID: 17018845

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW
Kidney international. 2005 Oct;68(4):1554-61.
PMID: 16164632

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.
Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005;20(7):1320-8.
PMID: 15840669

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
Wolf G, Chen S, Ziyadeh FN
Diabetes. 2005;54(6):1626-34.
PMID: 15919782

Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes.
Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN
Diabetes. 2004 Nov;53(11):2939-49.
PMID: 15504975

Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose.
Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, Ziyadeh FN
Kidney international. 2004;65(4):1191-204.
PMID: 15086458

Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
Chen S, Jim B, Ziyadeh FN
Seminars in nephrology. 2003 Nov;23(6):532-43.
PMID: 14631561

Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V, Mampaso F, Sepulveda-Munoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodriguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ
British journal of pharmacology. 2003;139(4):823-31.
PMID: 12813006

Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells.
Cohen MP, Shea E, Chen S, Shearman CW
The Journal of laboratory and clinical medicine. 2003;141(4):242-9.
PMID: 12677169

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.
Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN
Biochemical and biophysical research communications. 2003;300(1):16-22.
PMID: 12480514

Eudora Eng, MD
HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
Zeng L, Xu H, Chew TL, Eng E, Sadeghi MM, Adler S, Kanwar YS, Danesh FR
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005 Nov;19(13):1845-7.
PMID: 16160062

Hypoxia regulates PDGF-B interactions between glomerular capillary endothelial and mesangial cells.
Eng E, Holgren C, Hubchak S, Naaz P, Schnaper HW
Kidney international. 2005;68(2):695-703.
PMID: 16014047

Diminished NF-kappaB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress.
Eng E, Ballermann BJ
Microvascular research. 2003;65(3):137-44.
PMID: 12711254

John J. Friedewald, MD
Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE
Transplant international : official journal of the European Society for Organ Transplantation. 2006;19(2):128-39.
PMID: 16441362

Vascular and nonvascular complications of renal transplants: sonographic evaluation and correlation with other imaging modalities, surgery, and pathology.
Friedewald SM, Molmenti EP, Friedewald JJ, Dejong MR, Hamper UM
Journal of clinical ultrasound : JCU. 2005;33(3):127-39.
PMID: 15756666

Inflammatory cells in ischemic acute renal failure.
Friedewald JJ, Rabb H
Kidney international. 2004;66(2):486-91.
PMID: 15253694

Lorenzo Gallon, MD
Impact of Anemia after Renal Transplantation on Patient and Graft Survival and on Rate of Acute Rejection.
Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L
Clinical journal of the American Society of Nephrology : CJASN. 2008.
PMID: 18463170

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients.
Kasiske BL, de Mattos A, Flechner SM, Gallon L, Meier-Kriesche HU, Weir MR, Wilkinson A
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008.
PMID: 18510633

Long-Term Renal Transplant Function in Recipient of Simultaneous Kidney and Pancreas Transplant Maintained With Two Prednisone-Free Maintenance Immunosuppressive Combinations: Tacrolimus/Mycophenolate Mofetil Versus Tacrolimus/Sirolimus.
Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB
Transplantation. 2007;83(10):1324-1329.
PMID: 17519781

Leukopenia Complicates Cytomegalovirus Prevention After Renal Transplantation With Alemtuzumab Induction.
Walker JK, Scholz LM, Scheetz MH, Gallon LG, Kaufman DB, Rachwalski EJ, Abecassis MM, Leventhal JR
Transplantation. 2007;83(7):874-882.
PMID: 17460557

Role of {beta}3 Integrin in Acute Renal Allograft Rejection in Humans.
Chandrakantan A, McDermott DH, Bich Tran HT, Jurewicz M, Gallon L, Gaston R, Milford E, Abdi R
Clinical journal of the American Society of Nephrology : CJASN. 2007.
PMID: 17928472

Anti-CD20 Monoclonal Antibody (Rituximab) for the Treatment of Recurrent Idiopathic Membranous Nephropathy in a Renal Transplant Patient.
Gallon L, Chhabra D
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006 Dec;6(12):3017-21.
PMID: 17150083

Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient.
Gallon L, Chhabra D
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006 Dec;6(12):3017-21.
PMID: 17294527

Effect of Prednisone versus No Prednisone as Part of Maintenance Immunosuppression on Long-Term Renal Transplant Function.
Gallon LG, Winoto J, Leventhal JR, Parker MA, Kaufman DB
Clinical journal of the American Society of Nephrology : CJASN. 2006;1(5):1029-38.
PMID: 17699323

Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF.
Gallon L, Perico N, Dimitrov BD, Winoto J, Remuzzi G, Leventhal J, Gaspari F, Kaufman D
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6(7):1617-23.
PMID: 16827862

Immunophenotypic Analysis of Cellular Infiltrate of Renal Allograft Biopsies in Patients with Acute Rejection after Induction with Alemtuzumab (Campath-1H).
Gallon L, Gagliardini E, Benigni A, Kaufman D, Waheed A, Noris M, Remuzzi G
Clinical journal of the American Society of Nephrology : CJASN. 2006;1(3):539-45.
PMID: 17699257

Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results.
Kaufman DB, Leventhal JR, Gallon LG, Parker MA
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6(2):331-9.
PMID: 16426317

ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients.
Gallon L, Akalin E, Lynch P, Rothberg L, Parker M, Schiano T, Abecassis M, Murphy B
Transplantation. 2006;81(3):463-8.
PMID: 16477235

Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results.
Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005 Oct;5(10):2539-48.
PMID: 16162205

Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients.
Axelrod D, Leventhal JR, Gallon LG, Parker MA, Kaufman DB
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005;5(6):1423-9.
PMID: 15888050

Cybele Ghossein, MD
Increased complication rates of cardiac rhythm management devices in ESRD patients.
Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, Passman R
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2007;49(5):656-63.
PMID: 17472848

Stabilization of Glomerular Filtration Rate in Advanced Chronic Kidney Disease: A Two-Year Follow-up of a Cohort of Chronic Kidney Disease Patients Stages 4 and 5.
Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D
Advances in chronic kidney disease. 2007;14(1):105-12.
PMID: 17200050

Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information.
Scheetz MH, Scarsi KK, Ghossein C, Hurt KM, Zembower TR, Postelnick MJ
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;42(3):436-7; author reply 437-8.
PMID: 16392098

Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.
Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2005;15(3):345-55.
PMID: 16007564

Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Singri N, Johnstone D, Paparello J, Khosla N, Ahya SN, Ghossein C, Schlueter W, Rosa R, Batlle D, Levin ML
Advances in chronic kidney disease. 2004 Oct;11(4):398-403.
PMID: 15492978

Secondary IgA nephropathy presenting as nephrotic syndrome with glomerular crescentic changes and acute renal failure in a patient with autoimmune hepatitis.
Singri N, Gleason B, Flamm SL, Kanwar YS, Ghossein C
Journal of nephrology. 2004;17(1):125-9.
PMID: 15151269

Peter T. Ivanovich, MD
The WAA. Message from the president.
Ivanovich P
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2003;29(1):99-100.
PMID: 12877900

Vascular access and patient outcomes in hemodialysis: questions answered in recent literature.
Anel RL, Yevzlin AS, Ivanovich P
Artificial organs. 2003;27(3):237-41.
PMID: 12662209

Neenoo Khosla, MD
Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Singri N, Johnstone D, Paparello J, Khosla N, Ahya SN, Ghossein C, Schlueter W, Rosa R, Batlle D, Levin ML
Advances in chronic kidney disease. 2004 Oct;11(4):398-403.
PMID: 15492978

Murray L. Levin, MD
Acute renal failure.
Singri N, Ahya SN, Levin ML
JAMA : the journal of the American Medical Association. 2003;289(6):747-51.
PMID: 12585954

Xunrong Luo, MD, PhD
Two Rare Forms of Renal Allograft Glomerulopathy During Cytomegalovirus Infection and Treatment.
Luo X, Rajagopal A, Ison M, Friedewald J, Leventhal J, Kanwar Y
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2008.
PMID: 18423808

Cutting Edge: TGF-{beta}-Induced Expression of Foxp3 in T cells Is Mediated through Inactivation of ERK.
Luo X, Zhang Q, Liu V, Xia Z, Pothoven KL, Lee C
Journal of immunology (Baltimore, Md. : 1950). 2008;180(5):2757-61.
PMID: 18292494

Hyperexpression of Foxp3 and IDO During Acute Rejection of Islet Allografts.
Yang H, Ding R, Sharma VK, Hilaire FS, Lagman M, Li B, Thomas DA, Luo X, Song P, Stauffer C, August P, Suthanthiran M
Transplantation. 2007;83(12):1643-1647.
PMID: 17589350

Dendritic cells with TGF-{beta}1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M
Proceedings of the National Academy of Sciences of the United States of America. 2007.
PMID: 17307871

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM
The Journal of experimental medicine. 2007.
PMID: 17210729

Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching.
Tambur AR, Buckingham M, McDonald L, Luo X
Clinical transplants. 2006:399-404.
PMID: 18365396

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M
Transplantation. 2005;79(9):1091-6.
PMID: 15880049

James J. Paparello, MD
Stabilization of Glomerular Filtration Rate in Advanced Chronic Kidney Disease: A Two-Year Follow-up of a Cohort of Chronic Kidney Disease Patients Stages 4 and 5.
Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D
Advances in chronic kidney disease. 2007;14(1):105-12.
PMID: 17200050

Effects of statin therapy on the progression of chronic kidney disease.
Shah S, Paparello J, Danesh FR
Advances in chronic kidney disease. 2005;12(2):187-95.
PMID: 15822054

Effect of predialysis eating on measurement of urea reduction ratio and Kt/V.
Singri N, Johnstone D, Paparello J, Khosla N, Ahya SN, Ghossein C, Schlueter W, Rosa R, Batlle D, Levin ML
Advances in chronic kidney disease. 2004 Oct;11(4):398-403.
PMID: 15492978

Robert M. Rosa, MD
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y
JAMA : the journal of the American Medical Association. 2006;295(5):527-35.
PMID: 16449618

Racial differences in potassium disposal.
Suh A, DeJesus E, Rosner K, Lerma E, Yu W, Young JB, Rosa RM
Kidney international. 2004;66(3):1076-81.
PMID: 15327401

Stuart M. Sprague, DO
Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol.
Zisman AL, Ghantous W, Schinleber P, Roberts L, Sprague SM
American journal of nephrology. 2005 Nov;25(6):591-5.
PMID: 16282676

Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from blood.
Daniels CM, Woolverton EM, Sprague SM, Ameer GA
Blood purification. 2005;23(4):287-97.
PMID: 15942167

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005;20(10):2186-93.
PMID: 16030053

Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlethwaite JR, Sprague SM
Transplantation. 2004 Oct;78(8):1233-6.
PMID: 15502727

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Coburn JW, Maung HM, Elangovan L, Germain MJ, Lindberg JS, Sprague SM, Williams ME, Bishop CW
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004;43(5):877-90.
PMID: 15112179

Osteoporosis in chronic kidney disease.
Cunningham J, Sprague SM, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodriguez M, Stehman-Breen C, Stern P, Weisinger J, Osteoporosis Work Group
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004;43(3):566-71.
PMID: 14981616

Bone disease after kidney transplantation.
Sprague SM, Josephson MA
Seminars in nephrology. 2004;24(1):82-90.
PMID: 14730514

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.
Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2004;19(5):1174-81.
PMID: 15004264

Dialysis-related amyloidosis.
Dzido G, Sprague SM
Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2003;55(2):121-9.
PMID: 12847416

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D
Kidney international. 2003;63(4):1483-90.
PMID: 12631365

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ
Kidney international. 2003;63(1):248-54.
PMID: 12472790